Power Law company profile

908 Devices

Biotech & Life Sciences · Broadway, United States · Founded 2012 · IPO 2021 Colt

Mass Spectrometry and chemical analysis

Valuation

$147M

Market cap · May/2026

Revenue

$56M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

8 investors on 908 Devices's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

In-Q-Tel

ARCH Venture Partners

Razor's Edge Ventures

Series B+ 5 investors entered at this stage

Casdin Capital

Cormorant Asset Management

Aramco Ventures

Northpond Ventures

Tao Capital Partners

Global footprint

Where 908 Devices has talent and traffic

Workforce by country

🇺🇸 United States · Broadway HQ

Book a demo for the full country breakdown

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States62.1%

🇳🇬 Nigeria14.2%

🇨🇦 Canada7.1%

🇬🇧 United Kingdom4.6%

🇮🇳 India4.2%

Top 5 markets shown

Market sentiment

What the market is saying about 908 Devices

An AI-synthesized read of the highest-engagement posts about 908 Devices on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 908 Devices on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles